Fangzhou Inc. has clinched a dual honor as its H2H Smart Healthcare Ecosystem becomes one of Guangzhou’s Top 10 AI+Healthcare Cases, while the company itself lands the title of “Most Promising Enterprise” on the city’s 2024 Artificial Intelligence Innovation Development List. The awards, issued by Guangzhou’s science and technology authorities, highlight its AI-powered healthcare innovations.
“This validates our success in creating scalable, real-world AI solutions for healthcare,” said Dr. Xie Fangmin, founder and CEO of Fangzhou. “Our focus remains on building smarter systems that make healthcare more efficient and accessible for everyone.”
Fangzhou fused Tencent Health’s DeepSeek-V3 and DeepSeek-R1 AI models into its upgraded AI Agent 2.0 platform, using Tencent Cloud’s infrastructure to boost drug logistics and patient care efficiency.
Four tools—AI Physician Assistant, AI Customer Engagement Assistant, AI Procurement Orchestrator, and AI Content Assistant—power the H2H platform, streamlining diagnostics to supply chain operations while enhancing customer experiences.
Fangzhou’s chronic disease management platform connects 49.2 million users and 223,000 physicians, delivering personalized care and precision medicine services as of December 2024. Now in its third year, the initiative spotlights top AI-driven enterprises while boosting collaboration to fuel Guangzhou’s expanding tech ecosystem.
